MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Thousand (K) dollars
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Clinical developments
-
-
631
-
Other segments expenses
-
-
648
-
Net loss
-223
-229
-273
-255
Interest accrued on short term loan
9
-
-
-
Share-based compensation
-
-
1
39
Interest accrued
-
3
-
-
Depreciation
1
-
-
-
Other current assets
5
-2
-
-6
Related parties
364
-
291
191
Account payables and related parties
-
176
-
-
Account payables and accrued expenses
33
-
31
2
Net cash used in operating activities
0
-44
46
-17
Receipt of a loan
-
-
-7
-
Proceeds from issuance of common stock and warrants
-
-
3
0
Net cash provided by financing activities
-
-
-4
0
Change in cash and cash equivalents
0
-44
42
-17
Cash and cash equivalents at the beginning of the period
1
45
3
19
Cash and cash equivalents at the end of the period
1
1
45
3
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
No Cash Flow statement diagram available.
Buy us a coffee
Raphael Pharmaceutical Inc. (RAPH)
Raphael Pharmaceutical Inc. (RAPH)